It is currently unclear whether residual virus replication occurs in HIV-infected individuals on ART, and whether this replication could be a barrier to achieving an HIV cure.
In his latest blog, Russ J Spjut, PharmD, owner of Formulary Intel Consulting, discusses how a newly approved HIV treatment could offer hope for low adherence populations due to its low administration...
The use of second line antiretroviral therapy with ritonavir and lopinavir has increased in recent years, but at this time, little is known about the safety of tenofovir co-administration with LPV/r.
Mylan plans to improve access and increase costs savings within the $20 billion antiretroviral marketplace, by launching 2 of its HIV combination treatments—Symfi Lo and Cimduo—at a significant discount...
Neurological complications are known to be major contributors to morbidity and mortality in patients with HIV. In a recent review, researchers investigated how HIV-associated neurological complications...
Using data from the National HIV Surveillance System, the authors of a recent study sought to estimate the incidence and prevalence of HIV and percentage of undiagnosed HIV among various populations.
While sleep apnea and heart failure have been reported among individuals with HIV, there is currently no data characterizing the presence, association, and prognostic significance of SA among HIV-infected...
